SERPINA3 and amyloidosis: In fact, a CSF proteomic study in the APPPS1 mouse model of amyloidosis highlighted increased levels of proteins related to glial activation and identified APOE and SERPINA3 as CSF biomarkers (Eninger et al., 2022).